Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Marber

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Cardiovascular Research|June 14, 2018
The future of myocardial injury biomarkers in cardiovascular disease: looking beyond cardiac troponinsMichael Marber
Frontiers in Pharmacology|June 2, 2015
The case for inhibiting p38 mitogen-activated protein kinase in heart failurePelin Arabacilar, Michael Marber
Journal of the American College of Cardiology|October 19, 2006
Endothelial progenitors: a new Tower of Babel?Jonathan Leor, Michael Marber
European Heart Journal|February 27, 2004
Trends in incidence and prognosis of heart failure; You always pass failure on the way to successMark T Kearney, Michael Marber
Journal of Clinical Medicine|January 8, 2025
How Close Are We to Patient-Side Troponin Testing?Aaron Goldberg, Samuel McGrath, Michael Marber
European Heart Journal|June 12, 2004
Stem cells in unstable angina: the dynamic duoDivaka Perera, Gajen Kanaganayagam, Michael Marber
Postgraduate Medical Journal|May 24, 2015
Troponins and other biomarkers in the early diagnosis of acute myocardial infarctionAnnette Maznyczka, Thomas Kaier, Michael Marber
The New England Journal of Medicine|August 5, 2011
CABG in patients with left ventricular dysfunctionDivaka Perera, Simon Redwood, Michael Marber
Expert Review of Cardiovascular Therapy|November 9, 2025
Myocardial injury biomarkers and their assays: advances, insights, and future directionsSamuel McGrath, Bashir Alaour, Michael Marber
Cardiovascular Drugs and Therapy|January 9, 2019
Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial InfarctionThomas E Kaier, Bashir Alaour, Michael Marber
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Cardiovascular Research|June 14, 2018
The future of myocardial injury biomarkers in cardiovascular disease: looking beyond cardiac troponinsMichael Marber
Frontiers in Pharmacology|June 2, 2015
The case for inhibiting p38 mitogen-activated protein kinase in heart failurePelin Arabacilar, Michael Marber
Journal of the American College of Cardiology|October 19, 2006
Endothelial progenitors: a new Tower of Babel?Jonathan Leor, Michael Marber
European Heart Journal|February 27, 2004
Trends in incidence and prognosis of heart failure; You always pass failure on the way to successMark T Kearney, Michael Marber
Journal of Clinical Medicine|January 8, 2025
How Close Are We to Patient-Side Troponin Testing?Aaron Goldberg, Samuel McGrath, Michael Marber
European Heart Journal|June 12, 2004
Stem cells in unstable angina: the dynamic duoDivaka Perera, Gajen Kanaganayagam, Michael Marber
Postgraduate Medical Journal|May 24, 2015
Troponins and other biomarkers in the early diagnosis of acute myocardial infarctionAnnette Maznyczka, Thomas Kaier, Michael Marber
The New England Journal of Medicine|August 5, 2011
CABG in patients with left ventricular dysfunctionDivaka Perera, Simon Redwood, Michael Marber
Expert Review of Cardiovascular Therapy|November 9, 2025
Myocardial injury biomarkers and their assays: advances, insights, and future directionsSamuel McGrath, Bashir Alaour, Michael Marber
Cardiovascular Drugs and Therapy|January 9, 2019
Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial InfarctionThomas E Kaier, Bashir Alaour, Michael Marber
Pageof 8